These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10892368)

  • 21. [Gene therapy of peripheral vascular diseases].
    Morishita R; Ogiwara T
    Nihon Naika Gakkai Zasshi; 2000 Apr; 89(4):791-7. PubMed ID: 10876941
    [No Abstract]   [Full Text] [Related]  

  • 22. Vascular endothelial growth factor: gene therapy and therapeutic angiogenesis.
    Isner JM
    Am J Cardiol; 1998 Nov; 82(10A):63S-64S. PubMed ID: 9860364
    [No Abstract]   [Full Text] [Related]  

  • 23. Healing of a free tracheal autograft is enhanced by topical vascular endothelial growth factor in an experimental rabbit model.
    Dodge-Khatami A; Backer CL; Holinger LD; Mavroudis C; Cook KE; Crawford SE
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):554-61. PubMed ID: 11547309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb?
    Francis SC; Raizada MK; Mangi AA; Melo LG; Dzau VJ; Vale PR; Isner JM; Losordo DW; Chao J; Katovich MJ; Berecek KH
    Physiol Genomics; 2001 Dec; 7(2):79-94. PubMed ID: 11773594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Development of new therapeutics based on the concept "death and regeneration"].
    Morishita R; Ogihara T
    Nihon Ronen Igakkai Zasshi; 2000 Mar; 37(3):198-201. PubMed ID: 10879066
    [No Abstract]   [Full Text] [Related]  

  • 26. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT).
    Hedman M; Hartikainen J; Syvänne M; Stjernvall J; Hedman A; Kivelä A; Vanninen E; Mussalo H; Kauppila E; Simula S; Närvänen O; Rantala A; Peuhkurinen K; Nieminen MS; Laakso M; Ylä-Herttuala S
    Circulation; 2003 Jun; 107(21):2677-83. PubMed ID: 12742981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic angiogenesis awakens hope. New blood vessels for arterial occlusive disease patients? (interview by Dr. Judith Neumaier)].
    Diehm C
    MMW Fortschr Med; 2002 Jul; 144(27-28):14. PubMed ID: 12198872
    [No Abstract]   [Full Text] [Related]  

  • 28. [New horizons in revascularization: neoangiogenesis].
    Indolfi C; Stabile E; Esposito G; Perrino C; Cavuto L; Guerrera L; Chiariello M
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):565-7. PubMed ID: 12497784
    [No Abstract]   [Full Text] [Related]  

  • 29. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization.
    Isner JM; Asahara T
    J Clin Invest; 1999 May; 103(9):1231-6. PubMed ID: 10225965
    [No Abstract]   [Full Text] [Related]  

  • 30. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
    Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
    Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic medicine gets real.
    Abbott A
    Nature; 2001 May; 411(6836):410-2. PubMed ID: 11373641
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume.
    Harrigan MR; Ennis SR; Sullivan SE; Keep RF
    Acta Neurochir (Wien); 2003 Jan; 145(1):49-53. PubMed ID: 12545262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stem cells combined with gene transfer for therapeutic vasculogenesis: magic bullets?
    Nabel EG
    Circulation; 2002 Feb; 105(6):672-4. PubMed ID: 11839618
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapeutic angiogenesis: a new frontier for vascular therapy.
    Isner JM
    Vasc Med; 1996; 1(1):79-87. PubMed ID: 9546920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene therapy for coronary artery disease.
    Rosengart TK; Hillebrand K
    Adv Card Surg; 2001; 13():107-20. PubMed ID: 11209652
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapeutic angiogenesis using genetic transfection. An in vitro quantitative and functional study after gene code transfer for vascular endothelial growth factor].
    Zaric V; Weltin D; Stephan D
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):987-91. PubMed ID: 10989743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression.
    Sun X; Kanwar JR; Leung E; Lehnert K; Wang D; Krissansen GW
    Cancer Gene Ther; 2001 Oct; 8(10):719-27. PubMed ID: 11687895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Manipulating angiogenesis against vascular disease.
    Isner JM
    Hosp Pract (1995); 1999 Jun; 34(6):69-74, 76, 79-80 passim. PubMed ID: 10386112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Technology evaluation: VEGF165 gene therapy, Valentis Inc.
    Morse MA
    Curr Opin Mol Ther; 2001 Feb; 3(1):97-101. PubMed ID: 11249737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient expression of the vascular endothelial growth factor gene in vitro and in vivo, using an adeno-associated virus vector.
    Byun J; Heard JM; Huh JE; Park SJ; Jung EA; Jeong JO; Gwon HC; Kim DK
    J Mol Cell Cardiol; 2001 Feb; 33(2):295-305. PubMed ID: 11162134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.